To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·11-08 07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 81,302 shares, the number of shares held decreased 7.62% compared to the previous period and now represents 3.91% of the total position.
      514Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-08 07:13
      ARKG Investment Tracker position change: Decreased position in Personalis by 14,185 shares, the number of shares held decreased 90.76% compared to the previous period and now represents 0.0012% of the total position.
      322Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-08 07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 4,455 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 4.86% of the total position.
      87Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-08 07:13
      ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 28,395 shares, the number of shares held decreased 1.71% compared to the previous period and now represents 1.07% of the total position.
      230Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-08 07:13
      ARKG Investment Tracker position change: Increased position in Veracyte by 138,127 shares, the number of shares held increased 8.39% compared to the previous period and now represents 2.22% of the total position.
      170Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-08 07:13
      ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 53,820 shares, the number of shares held decreased 1.71% compared to the previous period and now represents 4.17% of the total position.
      314Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-08 07:13
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 275,445 shares, the number of shares held decreased 1.71% compared to the previous period and now represents 2.88% of the total position.
      793Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-08 07:13
      ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 44,205 shares, the number of shares held decreased 1.71% compared to the previous period and now represents 7.68% of the total position.
      318Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-08 07:13
      ARKG Investment Tracker position change: Decreased position in Illumina by 7,005 shares, the number of shares held decreased 1.71% compared to the previous period and now represents 4.36% of the total position.
      229Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·11-08 07:13
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 40,575 shares, the number of shares held decreased 1.71% compared to the previous period and now represents 3.49% of the total position.
      116Comment
      Report
       
       
       
       

      Most Discussed